Publications of Tiago F. Outeiro
All genres
Journal Article (100)
61.
Journal Article
18 (6), foy066 (2018)
The trehalose protective mechanism during thermal stress in Saccharomyces cerevisiae: the roles of Ath1 and Agt1. FEMS Yeast Research 62.
Journal Article
6, 79 (2018)
Membrane binding, internalization, and sorting of alpha-synuclein in the cell. Acta Neuropathologica Communications 63.
Journal Article
Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, 10.1038/s41380-018-0110-9 (2018)
64.
Journal Article
8, 6965 (2018)
(Poly)phenol-digested metabolites modulate alpha-synuclein toxicity by regulating proteostasis. Scientific Reports 65.
Journal Article
114 (5), pp. 1036 - 1045 (2018)
Binding modes of phthalocyanines of amyloid β peptide and their effects on amyloid fibril formation. Biophysical Journal 66.
Journal Article
Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study. World journal of biological psychiatry, 10.1080/15622975.2017.1417636 (2018)
67.
Journal Article
37 (1), pp. 139 - 159 (2018)
Glyoxal as an alternative fixative to formaldehyde in immunostaining and super-resolution microscopy. EMBO Journal 68.
Journal Article
55, pp. 5269 - 5281 (2018)
Implications of fALS mutations on Sod1 function and oligomerization in cell models. Molecular Neurobiology 69.
Journal Article
5 (1), pp. 4 - 31 (2018)
Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell 70.
Journal Article
8 (1), pp. 33 - 43 (2018)
Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson's disease. Journal of Parkinson's Disease: JPD 71.
Journal Article
119, pp. 121 - 135 (2018)
Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function. Neurobiology of Disease 72.
Journal Article
115 (41), pp. 10481 - 10486 (2018)
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America 73.
Journal Article
9, 97 (2017)
The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome 74.
Journal Article
20 (11), pp. 1569 - 1579 (2017)
Alpha-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nature Neuroscience 75.
Journal Article
7, 13713 (2017)
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson's disease. Scientific Reports 76.
Journal Article
32 (9), pp. 1331 - 1333 (2017)
Neuromelanin magnetic resonance imaging of the Substantia Nigra in LRRK2-related Parkinson's disease. Movement Disorders 77.
Journal Article
295, pp. 77 - 87 (2017)
Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Experimental Neurology 78.
Journal Article
56, pp. 7 - 16 (2017)
Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway. Neurobiology of Aging 79.
Journal Article
73 (4), pp. 459 - 467 (2017)
IGF-I gene therapy in aging rats modulates hippocampal genes relevant to memory function. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences 80.
Journal Article
26 (12), pp. 2231 - 2246 (2017)
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Human Molecular Genetics